ELK1 and ureter neoplasm: Another possibility includes a higher proportion of muscle-invasive disease, where p-ELK1 expression is more likely stronger, in ureteral tumors (33 of 50 (66.0%)) than in renal pelvic tumors (25 of 45 (55.6%)).